HOME >> MEDICINE >> NEWS
NIAID awards $4 million to develop anti-radiation treatments

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has issued five awards totaling $4 million to fund the development of products that eliminate radioactive materials from the human body following radiological or nuclear exposure. The awards, which were granted under Project Bioshield authorities, complement NIAID's other medical countermeasure efforts to create safe and effective products of this type.

"These new grants will help identify new drug candidates that could be acquired by the strategic national stockpile of medical countermeasures, which is available to the public after a terrorist or nuclear attack or accidental radioactive exposure," says NIAID Director Anthony S. Fauci, M.D.

In the event of an attack by a nuclear explosive device or radiological "dirty bomb," individuals potentially could inhale, ingest or absorb through their skin radioactive atoms called radionuclides. Depending on the type of radionuclide that a person is exposed to, the particles may be excreted from the body or enter bones, organs or other tissues, which could have significant adverse health consequences. Through an initiative announced in 2005, NIAID already is working to speed the development of a series of products that can bind (chelate) internally with the radionuclides and eliminate (decorporate) them from the body. Radionuclide decorporation products currently are available in the strategic national stockpile, but NIAID is focusing on expanding the product pool, creating new treatments capable of eliminating a wider range of radionuclides, developing products that can eliminate radioactive material faster and in greater amounts; and developing products in formulations that could be distributed more easily in a mass casualty situation.

NIAID has awarded five grants totaling up to $4 million to fund work for a period of 18 months. The following principal investigators and univ
'"/>

Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
25-Sep-2006


Page: 1 2

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
5. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... Ariz. (PRWEB) , ... January 14, 2019 , ... After ... have opened a new clinic in Phoenix, Arcadia Allergy & Asthma. This new allergy ... School Road, making it a great one stop destination for any immunological and respiratory ...
(Date:1/14/2019)... ... , ... Early bird pricing for Medical Device Risk Management: Prepare for the ... complicated, conflicted, confusing. And it is getting even more complicated , The international standard ... the new standard adds new definitions, changes the clause numbering, introduces new requirements, changes ...
(Date:1/14/2019)... ... ... 2019. , Acupuncture, Dr. Wai Chu - Homdel , Dr. ... Jodar - Somerset , Dr. Barbara Knoll - Lavallette , Dr. Helen Law ... Reinhardt - Pequannock , Dr. Sylvester Rich - Bound Brook , Dr. Ross ...
(Date:1/13/2019)... (PRWEB) , ... January 12, 2019 , ... ... Professionals Committee (YPC) in conjunction with Temple University hosted a continuing education (CEU) ... and Mentees. The event aimed to create a series of talks to ...
(Date:1/11/2019)... ... January 11, 2019 , ... ... teams in its “Next Generation Captive Insurance Solutions for New Risk Challenges” essay ... , The three finalist teams are: , Christian ...
Breaking Medicine News(10 mins):
(Date:1/15/2019)... Mont. (PRWEB) , ... January 15, 2019 , ... WebBuy, ... 2019 ready to partner with more dealers eager to reach a demographic of customers ... or used vehicle from a dealer’s inventory and complete the purchase on the dealer’s ...
(Date:1/15/2019)... ... January 15, 2019 , ... ... background screening, compliance and credentialing solutions, announces it was recently acquired by ... solutions. Cisive caters to the complex challenges and program needs of large ...
(Date:1/15/2019)... , ... January 15, 2019 , ... ... Double Board-Certified, Ivy League-educated and fellowship-trained Facial Plastic and Reconstructive Surgeon . ... Plastic, Reconstructive & Laser Surgery in California, Dr. Ransom serves patients with a ...
Breaking Medicine Technology:
Cached News: